Dyskinesias Clinical Trials

A listing of Dyskinesias medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Arizona

Tucson Arizona

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Tucson Arizona

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Arkansas

Little Rock Arkansas 72211

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

California

Fountain Valley California 92708

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Fountain Valley California 92708

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Irvine California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Irvine California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Palo Alto California

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

View More ▼

Pasadena California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Pasadena California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Reseda California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Ventura California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Ventura California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Colorado

Aurora Colorado

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Boulder Colorado

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Boulder Colorado

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

District of Columbia

Washington District of Columbia

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Florida

Hollywood Florida 33021

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Hollywood Florida 33021

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Miami Florida

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Miami Florida

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Miami Florida

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

View More ▼

Miami Springs Florida 33166

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

North Palm Beach Florida

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

North Palm Beach Florida

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Sarasota Florida 34243

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Tampa Florida

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Tampa Florida

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Tampa Florida

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Georgia

Decatur Georgia 30030

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Illinois

Chicago Illinois 60612

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Chicago Illinois

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Chicago Illinois

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Naperville Illinois 60563

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Indiana

Indianapolis Indiana

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Indianapolis Indiana

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Indianapolis Indiana

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Iowa

Iowa City Iowa

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Kansas

Kansas City Kansas

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Kentucky

Lexington Kentucky

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Louisiana

Baton Rouge Louisiana 70810

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Baton Rouge Louisiana 70810

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Massachusetts

Boston Massachusetts

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Michigan

Ann Arbor Michigan

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Ann Arbor Michigan

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Ann Arbor Michigan

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Grand Rapids Michigan 49503

Patients are needed to participate in a clinical research study to evaluate Tardive Dyskinesia

Minnesota

Minneapolis Minnesota

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia

Missouri

Kansas City Missouri

A Phase 2 clinical study for patients with Primary Ciliary Dyskinesia